The testicular toxicity of tri-o-cresyl-phosphate (78308) (TOCP) was studied in rats. Male Fischer-344-rats were administered 0 or 150mg/kg TOCP daily by gavage for 3, 7, 10, 14, or 21 days. A separate group of animals was maintained for 98 days after dosing to observe the effects of recovery. The animals were observed for signs of neurotoxicity. They were killed 24 hours after the last dose and the testes were removed and weighed. Brain acetylcholinesterase (AChE) and testicular nonspecific esterase (NSE), neurotoxic-esterase (NTE), and beta-glucuronidase (BGD) were determined. Blood samples were obtained and assayed for serum luteinizing-hormone (LH), follicle-stimulating-hormone (FSH), and testosterone. Interstitial fluid testosterone content was also measured. Cauda epididymal sperm samples were obtained and motility and sperm density were measured. Testicular sections as well as sections from the spleen, liver, kidney, pancreas, pituitary and adrenal glands, and small intestine were examined for histopathological changes. Signs of acute cholinergic toxicity (lacrimation and diarrhea) were seen in 30 percent of the animals during the first 5 days. No signs of delayed neurotoxicity were seen. TOCP decreased sperm motility and density after 10 days. Relative testes weights were significantly decreased only in animals dosed for 21 days. Brain AChE and testicular NSE and NTE were decreased. BGD was not affected. TOCP did not decrease serum LH, FSH, or testosterone, or interstitial testosterone. A complete absence of germinal cells was seen in all treated animals. The tubules appeared to have decreased diameters, and the epididymides did not contain any sperm. These changes did not reverse during the recovery period. No histopathological changes were seen in other organs. The authors conclude that TOCP acts directly on the testes in rats and at the tested dose produces irreversible testicular lesions.
Links with this icon indicate that you are leaving the CDC website.
The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website.
Linking to a non-federal website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website.
You will be subject to the destination website's privacy policy when you follow the link.
CDC is not responsible for Section 508 compliance (accessibility) on other federal or private website.
For more information on CDC's web notification policies, see Website Disclaimers.
CDC.gov Privacy Settings
We take your privacy seriously. You can review and change the way we collect information below.
These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. They help us to know which pages are the most and least popular and see how visitors move around the site. All information these cookies collect is aggregated and therefore anonymous. If you do not allow these cookies we will not know when you have visited our site, and will not be able to monitor its performance.
Cookies used to make website functionality more relevant to you. These cookies perform functions like remembering presentation options or choices and, in some cases, delivery of web content that based on self-identified area of interests.
Cookies used to track the effectiveness of CDC public health campaigns through clickthrough data.
Cookies used to enable you to share pages and content that you find interesting on CDC.gov through third party social networking and other websites. These cookies may also be used for advertising purposes by these third parties.
Thank you for taking the time to confirm your preferences. If you need to go back and make any changes, you can always do so by going to our Privacy Policy page.